Skip to main content

Table 1 Patient demographics

From: Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia

 

Number of individuals (n = 543)

Proportion of total cohort (%)

Reported sex

  

Male

244

44.9

Female

228

42.0

Not reported

71

13.1

Age at time of testing

  

Fetus

88

16.2

Infant (birth-age 2)

160

29.5

Childhood (ages 3–10)

132

24.3

Puberty (ages 11–18)

67

12.3

Young adult (ages 19–40)

68

12.5

Adult (ages 41–66)

28

5.2

Panel received

  

Skeletal dysplasias core (up to 113 genes)

65

12.0

Comprehensive skeletal dysplasias and disorders (up to 251 genes)

269

49.5

Comprehensive growth disorders/skeletal dysplasias and disorders (up to 374 genes)

209

38.5